XML 24 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Series A Preferred Stock
Series B Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total Neonode Inc. Stockholders' Equity
Noncontrolling Interests
Beginning Balances at Dec. 31, 2012 $ 8,100   $ 146,677 $ 5 $ (138,615) $ 8,100
Beginning Balances, Shares at Dec. 31, 2012   33,331          
Stock option and warrant compensation expense to employees 2,656 2,656 2,656
Proceeds from sale of common stock, net of offering costs 6,892 $ 2 6,890 6,892
Proceeds from sale of common stock, net of offering costs, shares   1,169          
Common stock issued upon exercise of common stock warrants 714 $ 3 711 714
Common stock issued upon exercise of common stock warrants, shares   3,152          
Common stock issued upon exercise of common stock options 1,060 $ 1,060 1,060
Common stock issued upon exercise of common stock options, shares   241          
Exchange of Series A preferred stock for common stock   40          
Exchange of Series B preferred stock for common stock   1          
Foreign currency translation adjustment 6 $ 6 6
Net loss (13,080) $ (13,080) (13,080)
Ending Balances at Dec. 31, 2013 6,348 $ 38 $ 157,994 $ 11 $ (151,695) 6,348
Ending Balances, shares at Dec. 31, 2013   37,934          
Stock option and warrant compensation expense to employees, directors and vendors 1,729 1,729 1,729
Proceeds from sale of common stock, net of offering costs $ 9,253 $ 2 9,251 9,253
Proceeds from sale of common stock, net of offering costs, shares   2,500          
Common stock issued upon exercise of common stock warrants $ 36 36
Common stock issued upon exercise of common stock warrants, shares   21          
Foreign currency translation adjustment $ 138 $ 138 138
Net loss (14,234) $ (14,234) (14,234)
Ending Balances at Dec. 31, 2014 3,270 $ 40 $ 169,010 $ 149 $ (165,929) 3,270
Ending Balances, shares at Dec. 31, 2014   40,455          
Stock option and warrant compensation expense to employees, directors and vendors 1,075 1,075 1,075
Proceeds from sale of common stock, net of offering costs 5,422 $ 3 $ 5,419 5,422
Proceeds from sale of common stock, net of offering costs, shares   3,200          
Common stock issued upon exercise of common stock warrants 1 $ 1 1
Common stock issued upon exercise of common stock warrants, shares   151          
Foreign currency translation adjustment (103) $ (103) $ (103)
Noncontrolling interests Pronode - initial contribution 3 $ 3
Net loss (7,820) $ (7,820) $ (7,820) (15)
Ending Balances at Dec. 31, 2015 $ 1,845 $ 44 $ 175,504 $ 46 $ (173,749) $ 1,845 $ (12)
Ending Balances, shares at Dec. 31, 2015   83 43,806